Related Experiment Video

Updated: Jul 24, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Close intervention sessions complement intensive insulin therapy in paediatric diabetes: a longitudinal study

Jason Foran1, Aisling Egan1, Eric Somers1

  • 1Department of Diabetes and Endocrinology, Children's Health Ireland at Crumlin, Dublin, Ireland.

Archives of Disease in Childhood
|July 4, 2023
PubMed

Insights

Insulin pump therapy and intensive re-education significantly improve glycemic control in children and adolescents with diabetes. Pump users showed lower HbA1c levels, an effect lasting years, while re-education rapidly reduced elevated HbA1c.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Glycemic control in pediatric diabetes is crucial for long-term health.
  • Multidisciplinary team input and intensive insulin therapy are key management strategies.
  • Understanding the long-term impact of different insulin delivery methods and educational interventions is essential.

Purpose of the Study:

  • To evaluate the 13-year impact of multidisciplinary team input and intensive insulin therapy on glycemic control in pediatric diabetes patients.
  • To compare the effectiveness of insulin pump therapy versus multiple daily injections (MDIs) on HbA1c levels.
  • To assess the effect of intensive re-education on glycemic control.

Main Methods:

  • A matched pair analysis compared insulin pump users with those on MDIs.
  • Panel data regression analyzed the impact of intensive re-education and treatment type on HbA1c.
  • Data were collected from a tertiary pediatric diabetes center between 2007 and 2020.

Main Results:

  • Insulin pump therapy was associated with a sustained reduction in HbA1c compared to MDIs (ΔHbA1c=-0.53% at 6 months, robust to socioeconomic factors).
  • Intensive re-education led to a significant decrease in HbA1c (mean drop of -0.81% within 6 months), independent of socioeconomic status.
  • The benefits of pump therapy were observed for up to 8 years.

Conclusions:

  • Insulin pump therapy offers a significant and sustained improvement in glycemic control for children and adolescents with diabetes compared to MDIs.
  • Intensive re-education programs are effective in rapidly reducing elevated HbA1c levels in this population.
  • These findings support the integration of advanced insulin delivery systems and targeted educational interventions in pediatric diabetes care.
Abstract

Keywords:
EndocrinologyPaediatricsStatistics

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.2K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.2K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
233
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K